Stretch Marks Cream
NDC Package 84509-006-01
Package Information
Stretch Marks Cream (sesamum indicum (sesame) seed extract, prunus persica (peach) resin extract, sterculia urens gum, tripeptide-1, hexapeptide-9, acetyl tetrapeptide-9, palmitoyl pentapeptide-4, palmitoyl tetrapeptide-7, acetyl hexapeptide-8.) cream is stretch Marks cream,removes scars, repairs, and enhances skin elasticity. This formulation utilizes a cream delivery system. Marketed by Guangzhou Senmai Biotechnology Co., this product is identified by NDC 84509-006 and is authorized under FDA application M016.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Fruit Proteins - [EXT]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 84509 - Guangzhou Senmai Biotechnology Co.
- 84509-006 - Stretch Marks Cream
- 84509-006-01 - 50 mL in 1 BOTTLE
- 84509-006 - Stretch Marks Cream
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 84509-006-01 identifies a specific commercial package of 50 ml in 1 bottle of Stretch Marks Cream, a human over the counter drug labeled by Guangzhou Senmai Biotechnology Co.. This cream is formulated for topical use and contains acetyl hexapeptide-8; acetyl tetrapeptide-9; hexapeptide-9; palmitoyl pentapeptide-4; palmitoyl tetrapeptide-7; peach; prezatide; sesame seed; sterculia urens whole as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangzhou Senmai Biotechnology Co. on July 31, 2024. The current certification is valid through December 31, 2026.
How is this Guangzhou Senmai Biotechnology Co. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 84509000601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.